MedTrace Logo

Utilisation of Angiox® in European Practice

NCT01011504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2019

Last updated 2012-01-19

No results posted yet for this study

Summary

The objective of this study is to determine utilisation patterns in patients receiving Angiox® in participating European centres. Additionally, through the collection of descriptive safety and outcomes data, this study will contribute to the Risk Management strategy for Europe

Conditions

  • Stable Angina (SA)
  • NSTE-ACS (NSTEMI and UA)
  • STEMI (STE-ACS)

Sponsors & Collaborators

  • The Medicines Company

    lead INDUSTRY

Principal Investigators

  • Christoph Nienaber, Prof.

  • Martial Hamon, Prof

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-10-31
Completion
2010-12-31

Countries

  • France
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01011504 on ClinicalTrials.gov